Beilstein J. Org. Chem.2013,9, 2916–2924, doi:10.3762/bjoc.9.328
, unexpectedly, that the antagonist JDTic is a bivalent ligand: in addition to the orthosteric pocket occupied by morphinans, JDTic also occupies a distinct (allotopic) pocket. Mutagenesis data suggest that salvinorin A (1) also binds to this allotopic pocket, adjacent to the aspartate residue that anchors the
for linked, fused or merged bivalent derivatives of 1.
Keywords: allotopic; bivalent ligand; designed multiple ligand; JDTic; κ-opioid receptor; natural products; Salvinorin A; Introduction
The structure–activity relationships of salvinorin A (1), a potent and selective κ (kappa) opioid, have been
selective antagonist JDTic is shown. Essential residues for high affinity binding of 1, where mutation reproducibly reduces affinity ≥10-fold, are shown with thick bonds for emphasis [7][8][9]. These key residues are all located in transmembrane helices (TMs) 2 and 7. The surfaces of these residues are
PDF
Graphical Abstract
Figure 1:
Binding affinities of salvinorin A (1) and furan derivatives for κ-OR [5].